The UK's premier medical aesthetic conference

Sanofi Aventis

One Onslow Street, Guildford, Surrey, UK, GU1 4YS
Tel: 01483 554 287  |  Web: http://www.sculptra.co.uk  |  Email: gfd-sculptra@sanofi-aventis.com & gfd-succeev@sanofi-aventis.com

Sculptra™ is a collagen stimulator that reduces lines, wrinkles and folds and replaces the fullness of the face that has been lost by the ageing process. Sculptra™ – injectable poly-L-lactic acid – when injected into the dermis, works by stimulating facial collagen production. 

The new collagen creates volume to correct the signs of facial ageing resulting in improved:-

• Tissue elasticity

• Dermal firmness

• Tissue density

• Facial contours

to produce a long-lasting natural and youthful look.

Suitable areas for Sculptra are:

• The Periorbital region

• Temple concavities

• Buccal concavities

• Nasolabial folds

• Zygomatic atrophy

• Marionette lines

• The mental line

• Jowls 

Sculptra works gradually to give a natural effect. Usually 2-3 treatments are required and results should be noticeable after approximately 6 weeks, (however, in some patients this may take longer or require more treatments).

Clinical studies have shown that the results of Sculptra can last for up to 40 months 3 years, significantly longer than many other injectable treatments and dermal thickness  can increase to up to 3-fold.

The main ingredient (poly-L-lactic acid) of Sculptra has been used in medicine for over 25 years and has a good safety profile. It is biocompatible and biodegradable. Furthermore No allergy testing is required before treatment, unlike some other products.

Sculptra can only be administered by a qualified healthcare professional who has completed the Sculptra training programme certified by sanofi-aventis.

For more information on Sculptra call 0800 085246 or visit our website.

Sculptra™ is marketed by sanofi-aventis, one of the world’s leading pharmaceutical companies.